phorbol-12-myristate has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, DO; Blumberg, PM; Cataisson, C; Chen, J; Herrmann, MA; Keck, GE; Kelsey, JS; McGowan, KM; Petersen, ME; Yuspa, SH | 1 |
| Cataisson, C; Gerdes, M; Jurjus, RA; Pal-Ghosh, S; Rajjoub, L; Ryscavage, A; Shukla, A; Stepp, MA; Tadvalkar, G; Yuspa, SH | 1 |
2 other study(ies) available for phorbol-12-myristate and Skin Neoplasms
| Article | Year |
|---|---|
Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin.
Topics: Animals; Antineoplastic Agents; Bryostatins; Drug Design; Epidermis; Female; Keratinocytes; Mice, Inbred BALB C; Mice, Inbred SENCAR; Phorbol Esters; Protein Kinase C; Skin Neoplasms | 2016 |
Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis.
Topics: Animals; Carcinogens; Cell Transformation, Neoplastic; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Knockout; Papilloma; Phorbol Esters; Skin Neoplasms; Syndecan-1; Toxicity Tests, Acute; Toxicity Tests, Chronic | 2010 |